Deacons advises on HK$3,386 million open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited
May, 2015 - China
Deacons recently represented Haitong International Securities Company Limited as underwriter in relation to the HK$3,386 million open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited.
Hua Han Bio-Pharmaceutical Holdings Limited is an investment holding company. It manufactures and sells pharmaceutical, medicinal healthcare and biopharmaceutical products.
The team was led by partner Kelvan Cheung who was supported by associate Michelle Leung.
